You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2024

Litigation Details for Novartis Pharmaceuticals Corporation v. Hetero USA Inc.. (D. Del. 2019)

✉ Email this page to a colleague

« Back to Dashboard

Novartis Pharmaceuticals Corporation v. Hetero USA Inc.. (D. Del. 2019)

Docket	⤷ Sign Up	Date Filed	2019-10-29
Court	District Court, D. Delaware	Date Terminated
Cause	35:271 Patent Infringement	Assigned To	Richard Gibson Andrews
Jury Demand	None	Referred To
Patents	8,101,659
Link to Docket	External link to docket

Small Molecule Drugs cited in Novartis Pharmaceuticals Corporation v. Hetero USA Inc..

The small molecule drugs covered by the patent cited in this case are ⤷ Sign Up and ⤷ Sign Up .

Details for Novartis Pharmaceuticals Corporation v. Hetero USA Inc.. (D. Del. 2019)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
2024-08-12	433	Memorandum and Order	"'134 patent"), 8,101,659 (the '"659 patent"), and 8,796,331 (the '…alleging infringement of U.S. Patent Nos. 8,877,938 (the "'938 patent"), 9,388,134 (the "…quot;331 patent") by MSN and several other defendants. (D.I. 1). Only the '659 patent remains…DELAWARE In re Entresto (SacubitrilNalsartan) Patent …, 36, 51, 61, 70). This case is one of several patent infringement actions filed by Novartis against	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.